An oral 5-ASA delivery system has demonstrated significant alleviating effects in a DSS-induced colitis model, upregulating the expression of claudin-1, Occludin, and zonula occludens-1 (ZO-1) in NCM460 cells and enhancing intestinal epithelial barrier integrity (8). This evidence concerns the gene OCLN and colitis.